⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24344148 | 0.71 | — | — | |
| SCHEMBL18435931 | 0.71 | — | — | |
| SCHEMBL24331970 | 0.69 | — | — | |
| SCHEMBL18855236 | 0.65 | — | — | |
| SCHEMBL23623000 | 0.65 | — | — | |
| SCHEMBL23505961 | 0.65 | — | — | |
| SCHEMBL22515684 | 0.64 | — | — | |
| SCHEMBL22359674 | 0.64 | — | — | |
| SCHEMBL24738278 | 0.64 | — | — | |
| SCHEMBL11108393 | 0.62 | KDM4E (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2303428-B1 | ABSORBING SOLUTION CONTAINING A THIADIAZOLE-DERIVED DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBING SOLUTION | IFP Energies Nouvelles (FR) | 2016-02-10 | — | — | EP | claimed |
| US-20110110834-A1 | ABSORBENT SOLUTION CONTAINING A THIADIAZOLE-DERIVED DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBENT SOLUTION | IFP Energies Nouvelles (FR) | 2011-05-12 | — | — | US | claimed |
| WO-2010004119-A1 | ABSORBENT SOLUTION CONTAINING A SULPHUR-CONTAINING DEGRADATION INHIBITOR DERIVED FROM AN AMINO ACID AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBENT SOLUTION | IFP (FR) | 2010-01-14 | — | — | WO | claimed |
| EP-2303428-B1 | ABSORBING SOLUTION CONTAINING A THIADIAZOLE-DERIVED DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBING SOLUTION | IFP Energies Nouvelles (FR) | 2016-02-10 | — | — | EP | disclosed |
| US-9139512-B2 | Absorbent solution containing a degradation inhibitor derived from a triazole or from a tetrazole and method of absorbing acid compounds contained in a gaseous effluent | IFP Energies Nouvelles (FR) | 2015-09-22 | — | — | US | disclosed |
| US-20120148463-A1 | ABSORBENT SOLUTION CONTAINING A DEGRADATION INHIBITOR DERIVED FROM A TRIAZOLE OR FROM A TETRAZOLE AND METHOD OF ABSORBING ACID COMPOUNDS CONTAINED IN A GASEOUS EFFLUENT | IFP Energies Nouvelles (FR) | 2012-06-14 | — | — | US | disclosed |
| US-20110110834-A1 | ABSORBENT SOLUTION CONTAINING A THIADIAZOLE-DERIVED DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBENT SOLUTION | IFP Energies Nouvelles (FR) | 2011-05-12 | — | — | US | disclosed |
| EP-2303428-A2 | ABSORBING SOLUTION CONTAINING A THIADIAZOLE-DERIVED DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBING SOLUTION | IFP Energies nouvelles (FR) | 2011-04-06 | — | — | EP | disclosed |
| EP-0958356-B1 | A PROCESS OF MAKING A COMPOUND BY FORMING A POLYMER FROM A TEMPLATE DRUG | MIRUS BIO CORP (US) | 2010-04-14 | — | — | EP | disclosed |
| WO-2010004118-A1 | ABSORBENT SOLUTION CONTAINING A DEGRADATION INHIBITOR OF THE FAMILY OF DITHIOPHOSPHATES AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBENT SOLUTION | IFP (FR) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009156619-A2 | ABSORBING SOLUTION CONTAINING A THIADIAZOLE-DERIVED DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBING SOLUTION | IFP (FR) | 2009-12-30 | — | — | WO | disclosed |
| US-20020085989-A1 | Process of making a compound by forming a polymer from a template drug | ROCHE MADISON INC. | 2002-07-04 | — | — | US | disclosed |
| US-20020061287-A1 | Process of making a compound by forming a polymer from a template drug | Arrowhead Madison Inc. | 2002-05-23 | — | — | US | disclosed |
| EP-1073707-A4 | A PROCESS OF MAKING A COMPOUND BY FORMING A POLYMER FROM A TEMPLATE DRUG | MIRUS CORP (US) | 2002-03-13 | — | — | EP | disclosed |
| US-6339067-B1 | COVALENTLY FORMING A POLYMER, FROM MONOMERS, IN PRESENCE OF A POLYION, WHEREIN THE POLYMER IS FORMED OUTSIDE OF ANY CELL, RESULTING IN POLYMER--POLYION COMPLEX FOR DELIVERY TO A CELL, WHEREIN POLYION IS NOT REMOVED FROM COMPLEX | MIRUS CORPORATION | 2002-01-15 | — | — | US | disclosed |
| EP-1073707-A1 | A PROCESS OF MAKING A COMPOUND BY FORMING A POLYMER FROM A TEMPLATE DRUG | Mirus Corporation (US) | 2001-02-07 | — | — | EP | disclosed |
| US-6126964-A | MAKING A COMPLEX FOR DELIVERY TO A CELL, FORMING A POLYMER FROM MONOMERS IN THE PRESENCE OF POLYION FOR DELIVERY TO CELLS | MIRUS CORPORATION (US) | 2000-10-03 | — | — | US | disclosed |
| EP-0958356-A1 | A PROCESS OF MAKING A COMPOUND BY FORMING A POLYMER FROM A TEMPLATE DRUG | Mirus Corporation (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1999055825-A1 | A PROCESS OF MAKING A COMPOUND BY FORMING A POLYMER FROM A TEMPLATE DRUG | MIRUS CORPORATION (US) | 1999-11-04 | — | — | WO | disclosed |
| WO-1998029541-A1 | A PROCESS OF MAKING A COMPOUND BY FORMING A POLYMER FROM A TEMPLATE DRUG | MIRUS CORPORATION (US) | 1998-07-09 | — | — | WO | disclosed |